Organigram Global (OGI) Prepaid Assets (2018 - 2026)

Organigram Global (OGI) posted quarterly Prepaid Assets of $4.9 million for Q1 2026, down 36.85% quarter-over-quarter from $7.8 million in Q4 2025.

Organigram Global (OGI) Prepaid Assets (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Prepaid Assets for 9 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.

In Q1 2026, Prepaid Assets changed N/A year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $4.9 million (changed N/A YoY), while the FY2025 annual figure was $7.8 million, changed N/A from the prior year.
Prepaid Assets eased to $4.9 million in Q1 2026 per OGI's latest filing, from $7.8 million in the prior quarter.
Across five years, Prepaid Assets topped out at $8.5 million in Q3 2025 and bottomed at $4.9 million in Q1 2026.
Historically, Prepaid Assets has averaged $7.1 million across 5 years, with a median of $7.3 million in 2025.
Annual changes were most pronounced in 2024 — Prepaid Assets retreated 18.57% — and 2025, when it increased 26.83%.
Organigram Global's Prepaid Assets stood at $6.5 million in 2022, then advanced by 26.39% to $8.2 million in 2023, then declined by 18.57% to $6.7 million in 2024, then climbed by 17.26% to $7.8 million in 2025, then tumbled by 36.85% to $4.9 million in 2026.
Business Quant data shows OGI's Prepaid Assets at $4.9 million in Q1 2026, $7.8 million in Q4 2025, and $8.5 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Organigram Global	150.66 Mn	150.54 Mn	28.97 Mn

Download Data